Check out the companies making headlines in after-hours trading: Apple — The iPhone maker advanced 7% as it announced a $110 billion share repurchase and a top- and bottom-line beat. Apple’s fiscal second-quarter earnings came in at $1.53 per share, while revenue was $90.75 billion. That surpassed analysts’ estimates for earnings of $1.50 per share on revenue of $90.01 billion, per LSEG. Expedia — The online travel company dropped roughly 8% in after-hours trading. Expedia lowered its full-year guidance to a range of mid to high single-digit top-line growth, citing slowness in Vrbo and the rate of acceleration in business-to-consumer so far. Expedia posted a beat on first-quarter revenue, which came in at $2.89 billion, surpassing analysts’ estimates of $2.81 billion, per LSEG. Amgen — The biotech company surged 11%. Amgen posted adjusted earnings of $3.96 per share on revenue of $7.45 billion in the first quarter. Analysts polled by LSEG anticipated earnings of $3.87 per share and revenue of $7.44 billion. The company also said it would move its injectable obesity drug into a phase 3 trial, but it will no longer pursue an experimental weight loss pill it had in development. Fortinet — Shares of the security company tumbled 8%. The midpoint of Fortinet’s billings guidance for t …
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnCheck out the companies making headlines in after-hours trading: Apple — The iPhone maker advanced 7% as it announced a $110 billion share repurchase and a top- and bottom-line beat. Apple’s fiscal second-quarter earnings came in at $1.53 per share, while revenue was $90.75 billion. That surpassed analysts’ estimates for earnings of $1.50 per share on revenue of $90.01 billion, per LSEG. Expedia — The online travel company dropped roughly 8% in after-hours trading. Expedia lowered its full-year guidance to a range of mid to high single-digit top-line growth, citing slowness in Vrbo and the rate of acceleration in business-to-consumer so far. Expedia posted a beat on first-quarter revenue, which came in at $2.89 billion, surpassing analysts’ estimates of $2.81 billion, per LSEG. Amgen — The biotech company surged 11%. Amgen posted adjusted earnings of $3.96 per share on revenue of $7.45 billion in the first quarter. Analysts polled by LSEG anticipated earnings of $3.87 per share and revenue of $7.44 billion. The company also said it would move its injectable obesity drug into a phase 3 trial, but it will no longer pursue an experimental weight loss pill it had in development. Fortinet — Shares of the security company tumbled 8%. The midpoint of Fortinet’s billings guidance for t …nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
